Rating History for Eupraxia Pharmaceuticals (EPRX) by Stifel
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/20/2026 | Samimy Annabel | New Coverage | Buy (N/A) |
25.00 (N/A) |
6.29 (6.47) |
2.86% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/20/2026 | Samimy Annabel | New Coverage | Buy (N/A) |
25.00 (N/A) |
6.29 (6.47) |
2.86% | Details |